Navigation Links
Washington DC-area IVF Specialist Suheil Muasher, MD Addresses Fears of Infertility Treatments after Octuplet Mom News
Date:3/17/2009

case reflects badly on an area of science that has worked for decades to help women who have trouble getting pregnant. Dr. Muasher says he wants to reassure women who may be reconsidering IVF treatment because of the case in California. “We tell patients that the vast majority of IVF babies, greater than 97%, are either singletons or twins. There is no reason to fear IVF treatment simply because there is a higher chance of a multiple pregnancy.”

Dr. Muasher is head of The Muasher Center for Fertility and IVF, specializing in IVF for Washington DC, Fairfax, Virginia, and Maryland-area patients, as well as those from around the world. He participated in the original research that ultimately led to the IVF protocol used in most clinics today. Dr. Muasher says his facility tries to educate patients that the best possible outcome of in vitro fertilization is to have a healthy singleton baby. “Education is very important as many patients do not truly understand the increased risks of multiple pregnancy. We also try to follow the guidelines of our professional societies in limiting the number of embryos transferred.”

Those guidelines from ASRM stipulate that: women under 35 with a favorable prognosis of carrying a fetus to term should have 1-2 embryos transferred; those under 35 with less favorable prognoses should have 2 embryos transferred; women ages 35-37 (favorable prognosis) should have 2 embryos transferred; those with an unfavorable prognosis should have 3. The guidelines typically increase the number of embryos recommended for transfer depending on the patient’s age and prognosis, but the guideline never goes above a 5-embryo transfer recommendation (for patients over 40.

Dr. Muasher says although some individuals and couples would like to hav
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4

Related medicine news :

1. Extremely affordable health innovations at World Health Care Congress, April 14-16, Washington
2. An Incubator or Cataract Surgery for $25? Heart Bypass Surgery for $2,000? See How it Works at Extremely Affordable Health Innovations at The World Health Care Congress, April 14-16, Washington, DC
3. News media registration opens for ENDO 09 in Washington, D.C.
4. Washington Redskins Reed Doughty Named Honorary Chair of the National Kidney Foundations Inaugural Kidney Walk in Prince Georges County
5. Washington University Becker Library Makes MetaCore Accessible Throughout the University
6. Video: Celebrities and Professional Athletes Invite the Public to Join them at the Third Annual National Walk for Epilepsy on March 28, in Washington, D.C.
7. Seven Washington Organizations Receive Almost $126,000 Through March of Dimes Awards and Grants
8. Introducing HEAL-WA--New Initiative Brings Evidence-Based Health Sciences Information to Health Professionals in Washington State
9. Grandson of Slaves Wins Experience of a Lifetime, Heads to Washington, D.C. to Attend Presidential Inauguration Events
10. Radiation Victims to Rally In Washington - Demand Congressional Action to Protect Homebuyers; Organization Labels EPA's Radon Program a 'Deadly Failure'
11. Joint Mathematics Meetings in Washington, D.C.
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Washington DC-area IVF Specialist Suheil Muasher, MD Addresses Fears of Infertility Treatments after Octuplet Mom News
(Date:7/30/2014)... July 30, 2014 Good Neighbor ... in an upcoming episode of Innovations with Ed ... Channel. Dates and show times TBA. , In ... Neighbor Community Services’ vision to redefine the traditional ... and dynamic services. Through passion, innovation, determination, excellence, ...
(Date:7/30/2014)... WEDNESDAY, July 30, 2014 (HealthDay News) -- It can happen ... television, dresser or computer monitor and gets critically injured ... of a young child should look around their homes and ... a child. Imagining it is better than it becoming a ... Emergency Physicians, said in a college news release. Between ...
(Date:7/30/2014)... as well as evolutionary changes in a living organismhad ... throughout the genome. , However, recent studies have shown ... mutations that arise simultaneously and in close proximity to ... found in regions where chromosomal rearrangements take place. , ... , may one day lead to new cancer therapies, ...
(Date:7/30/2014)... July 30, 2014 Visitors to our ... over $8,500 to ensure its protection. Bob Kiesendahl, one ... check to the Delaware Highlands Conservancy for donations collected ... small $2-per-stay donations add up fast, as visitors welcome ... Upper Delaware River Region. , The Kiesendahl family has ...
(Date:7/30/2014)... 2014) The phrase "we caught it early" is possibly ... midst of a cancer diagnosis. Combating cancer in its ... certain part of the body, gives patients the best ... colon, prostate and other forms of cancer are touted ... providers recommend cancer screenings as a precautionary measure, especially ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News:Tip-Over Furniture Can Kill Kids 2Health News:Biologists describe mechanism promoting multiple DNA mutations 2Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 2Health News:UK psychologist creates patient tool to assist with lung cancer screening decision 3
... July 8 Fate Therapeutics, Inc. ... research on small molecule modulators of the Wnt pathway ... International Society for Stem Cell Research (ISSCR) in Barcelona, ... selected Wnt activators induce the differentiation of mesenchymal stem ...
... ... a name change to Freedom Disability and has expanded its operations into a new corporate ... growth of the business, bringing hundreds of new jobs to the state. , ... Shelton, CT (PRWEB) July 8, 2009 -- ...
... , HUNTINGTON BEACH, Calif., July 8 "You are what you ... what you drink may be as important as what you eat ... and many others, according to Dr. Cheryle Hart, medical advisor for ... . , , One study referred ...
... ... according to Ed Sinson, On-line Forum and Social Networking Representative. , ... Irvine, Calif. (Vocus) July 8, 2009 ... according to Ed Sinson, On-line Forum and Social Networking Representative. , , ,"We ...
... ... Parts Washers are growing in popularity. These parts washers are cost effective and quick ... economic climate. , ... (Vocus) July 8, 2009 -- Midbrook, a Jackson, MI based manufacturer of industrial parts ...
... created using embryonic stem cells for the first time in ... understanding of the causes of infertility. Researchers led ... England Stem Cell Institute (NESCI) have developed a new technique ... the laboratory. The work is published today (8th ...
Cached Medicine News:Health News:Fate Therapeutics to Present Data on Stimulation of Osteogenic Activity Using Small Molecule Modulators of Wnt Pathway 2Health News:National Social Security Disability Advocacy Firm Changes Name to "Freedom Disability" and Acquires 22,000 Square Foot Corporate Headquarters in Shelton, CT 2Health News:National Social Security Disability Advocacy Firm Changes Name to "Freedom Disability" and Acquires 22,000 Square Foot Corporate Headquarters in Shelton, CT 3Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 2Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 3Health News:Latest Studies Show 'Junk Drinks' Pose as Many Health Threats as 'Junk Food' According to AquaHydrate Medical Advisor 4Health News:Bariatric Advantage Participates in Social Networks 2Health News:Refurbished and Used Industrial Parts Washers Grow in Popularity 2Health News:Human sperm created from embryonic stem cells 2
(Date:7/30/2014)... PARIS , July 30, 2014  Regeneron ... (EURONEXT: SAN and NYSE: SNY ) today ... alirocumab in people with hypercholesterolemia met their primary efficacy ... low-density lipoprotein cholesterol (LDL-C) at 24 weeks compared to ... antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). ...
(Date:7/30/2014)... July 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: ... into the cannabis testing and education markets, announced today ... and affairs not previously disclosed or, to its knowledge, ... market action. "We have noticed unusual price ... three trading days," said Steve Barbee , CEO ...
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
Breaking Medicine Technology:Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8DigiPath No New Corporate Developments 2PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5
... 19, 2011 Families of Spinal Muscular Atrophy announced today ... and Drug Administration to commence a Phase I safety study ... being developed for Spinal Muscular Atrophy. FSMA ... stages of drug development, when risk is the highest.  It ...
... PRNewswire / -- Silicon Valley Bank ... companies worldwide, released a study today that ... capital-backed biotech and medical device companies. Based ... of US venture-capital backed companies (60 biotech and 58 ...
Cached Medicine Technology:Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 2Families of Spinal Muscular Atrophy Announces Repligen Corporation Receives FDA Approval to Begin Phase I Clinical Trial in SMA 3Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 2Venture-Backed Biotech Generates Quicker Exits but Lower Multiples than Medical Device 3
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Low-profile, hand-held instrument....
Medicine Products: